Arata Ishii1, Naoya Mimura1,2, Tatsuzo Mishina1, Atsuko Tsuneyama3, Yoshikazu Nakano3, Yasuhito Hatanaka1, Takaaki Tanami1, Jun Takiguchi1, Yurie Nagai1, Miki Yamazaki1, Kensuke Kayamori1, Kenji Kimura1, Yusuke Isshiki1, Koji Takaishi1, Yutaro Hino1, Nagisa Oshima1, Shokichi Tsukamoto1, Shio Mitsukawa1,2, Yusuke Takeda1, Masahiro Takeuchi1, Chikako Ohwada1, Tohru Iseki1,2, Sonoko Misawa3, Satoshi Kuwabara3, Chiaki Nakaseko1,4, Emiko Sakaida1 (1.Hematol., Chiba Univ. Hosp., Chiba, Japan, 2.Trans. Med. Cel. Ther., Chiba Univ. Hosp., Chiba, Japan, 3.Neurol., Chiba Univ. Hosp., Chiba, Japan, 4.Hematol., Int. Univ. Health and Welfare, Narita, Japan)
Session information
Poster Session
Sat. Oct, 13
Poster Session 2-27 MM: Complications
Sat. Oct 13, 2018 5:10 PM - 5:50 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)
Chair: Yoshiaki Kuroda (Department of Hematology and Oncology National Hospital Organization Kure Medical Center/ Chugoku Canser Center)
Tsuyoshi Muta1, Kazutaka Yamato1, Masayasu Hayashi3, Kentaro Kohno1, Kenichi Aoki1, Masakazu Higuchi4, Yoshikane Kikushige3, Toshihiro Miyamoto3, Koichi Akashi3, Koichi Ohshima5, Ryosuke Ogawa1 (1.JCHO Kyushu Hospital, 2.Department of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, 3.Department of Medicine and Biosystemic Science, Kyushu University, 4.Department of Hematology, JR Kyushu Hospital, 5.Department of Pathology, Kurume University School of Medicine)
Megumi Akiyama, Kosuke Arai, Junichi Mukae, Saeko Sonokawa, Atsushi Takahata, Koh Yamamoto (Dept. Hematology, Yokohama City Minato Red Cross Hospital, Kanagawa, Japan)
Naoko Harada, Mitsunori Ueno, Norikazu Mitsui, Shunichirou Yamaguchi, Toshiro Kawakita, Yoshiko Inoue, Tatsunori Sakai, Atsuko Tsukamoto, Tetsuyuki Kiyokawa, Michihiro Hidaka (National Hospital Organization Kumamoto Medical Center, Hematology Department, Kumamoto, Japan)
Rie Furuta1, Yawara Kawano1, Hiro Tatetsu1, Hideki Inoue2, Yoshitaka Kikukawa3, Yutaka Okuno1, Hiroyuki Hata4, Masao Matsuoka1 (1.Department of Hematology, Kumamoto University Hospital, Kumamoto, Japan, 2.Department of Nephrology, Kumamoto University Hospital, Kumamoto, Japan, 3.Department of Medical Oncology, Saiseikai Kumamoto Hospital, Kumamoto, Japan, 4.Division of Informative Clinical Sciences, Kumamoto University,Kumamoto, Japan)
Koji Takaishi1, Shokichi Tsukamoto1, Takaaki Tanami1, Yasuhito Hatanaka1, Jun Takiguchi1, Arata Ishii1, Yurie Nagai1, Tatsuzo Mishina1, Miki Yamazaki1, Yusuke Isshiki1, Kensuke Kayamori1, Kenji Kimura1, Yutaro Hino1, Nagisa Oshima1, Shio Mitsukawa1,2, Yusuke Takeda1, Naoya Mimura1,2, Chikako Ohwada1, Masahiro Takeuchi1, Chiaki Nakaseko1,3, Tohru Iseki1,2, Emiko Sakaida1 (1.Department of Hematology, Chiba University Hospital, Chiba, Japan, 2.Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, 3.Department of Hematology, International University of Health and Welfare)
Tadahiko Igarashi1, Naoya Murata1, Hiroyuki Irisawa1, Kayoko Murayama1, Masami Suzuki2 (1.Hematol/Oncol. Div., Gunma Cancer Ctr., Ohta-City, Japan, 2.Head/Neck Div., Gunma Cancer Ctr., Ohta-City, Japan)
Yoshiki Nakae, Masako Takemoto, Ruri Kato, Manabu Kawakami (NISSAY hospital Department of hematology and chemotherapy, Osaka, Japan)